Stifel Nicolaus Begins Coverage on Kestra Medical Technologies (NASDAQ:KMTS)

Stock analysts at Stifel Nicolaus started coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a note issued to investors on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $28.00 price target on the stock. Stifel Nicolaus’ target price would indicate a potential upside of 13.91% from the stock’s previous close.

Kestra Medical Technologies Price Performance

KMTS opened at $24.58 on Monday. Kestra Medical Technologies has a fifty-two week low of $20.00 and a fifty-two week high of $25.98.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.